A Phenotypical Brain Organoids for Neurodevelopmental Disorders
A Phenotypical Brain Organoids for Neurodevelopmental Disorders
批准号:
10526025
负责人:
Lu Wang
金额:
$10.56万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-05 至 2024-07-31
关键词:
3-DimensionalATAC-seqAffectAtlasesAwardBar CodesBiologicalBiological MarkersBrainBrain DiseasesBrain PathologyCategoriesCellsCharacteristicsChildhoodChromatinChronicClassificationClinicalCollaborationsComplexCoupledDataDefectDevelopmentDiseaseDisease modelEnvironmentEpigenetic ProcessEpilepsyEvaluationEventFeedbackFingerprintFoundationsFutureGene MutationGenesGeneticGenetic TranscriptionGenotypeGoalsHumanHypoxiaImpairmentIn VitroIndividualIntellectual functioning disabilityKnowledgeLeadLibrariesLightLinkLogisticsMaliMapsMentorsMethodsMicrocephalyMicrogyriaMicroscopeMicroscopyModelingMolecularMorphologyMutationNervous System PhysiologyNeurodevelopmental DisorderNeuronsOrganoidsOutcome MeasurePatientsPersonsPhasePhenotypePositioning AttributePrecision therapeuticsProteomicsReporterResearchResolutionSamplingSeizuresSolidSpecificityStressSystemTemperatureTestingThree-Dimensional ImagingTimeTrainingVirusVirus DiseasesWorkbasecausal variantcell typeclinical diagnosisclinically relevantdetectordrug developmentexperimental studygene environment interactionimprovedinduced pluripotent stem cellmouse modelnoveloptical imagingpromoterprotein expressionrelating to nervous systemskillssmall moleculestem cell fatetool
中文摘要
项目总结/摘要
神经发育障碍(NDD)的特征在于大脑发育中断,并且临床上
会导致神经功能受损NDD占慢性儿科疾病的约25%,无法治愈
并导致终身残疾。分子研究提高了我们对NDD的理解,但仍然很大。
存在知识差距。传统的研究工具,如小鼠模型,往往不能充分模拟
了以下条件来自患者来源的iPSC的人脑类器官(hBO)可以捕获许多特征
和大脑发育中的生物学事件。然而,我们仍然不知道人类NDD的效果如何
在hBO中建模。在这里,我建议调查的范围内的基因型-表型相关性观察,
来自750个独立系的独特患者来源的iPSC文库的hBO以测试四个假设:1] NDD-
衍生的hBO是潜在的临床脑病理学的敏感和特异的检测器。2]NDD衍生
hBO显示出细胞和分子标志,揭示了大脑发育中断的阶段。三、
应用于这些体外衍生的hBO的组学方法可以揭示其潜在的机制。
中断发展。4]基因-环境相互作用可以在hBO中进行询问。
该奖项的培训阶段,在格里森博士在加州大学圣地亚哥分校的实验室进行,概述了一个全面的计划,
获得技术和专业技能,使我能够过渡到独立研究
位置该项目的成功完成将为今后的实验提供一个平台,
联合收割机结合我在干细胞命运决定方面的专业知识,更深入地了解这些
转录、表观遗传和结构特异性导致神经发育脑障碍。
英文摘要
PROJECT SUMMARY/ABSTRACT
Neurodevelopmental disorders (NDDs) are characterized by disrupted development of the brain, and clinically
they lead to impaired neurological function. NDDs account for ~25% of chronic pediatric disease, are incurable
and result in lifelong impairments. Molecular studies have improved our understanding of NDDs, but still large
gaps in knowledge exist. Conventional research tools like the mouse model does not often adequately model
these conditions. Human brain organoids (hBOs) from patient-derived iPSCs can capture many characteristics
and biological events in the developing brain. However, we still do not know how well human NDDs can be
modeled in hBOs. Here, I propose to investigate the range of genotype-phenotype correlations observable in
hBOs from a unique patient derived iPSC library of 750 independent lines to test four hypotheses: 1] NDD-
derived hBOs are both sensitive and specific detectors of the underlying clinical brain pathology. 2] NDD-derived
hBOs show both cellular and molecular hallmarks revealing the stages of disrupted brain development. 3]
Omics approaches applied to these in-vitro derived hBOs can reveal underlying mechanisms of
disrupted development. 4] Gene-environment interactions can be interrogated in hBOs.
The training phase of the award, conducted in Dr. Gleeson’s lab at UCSD, outlines a comprehensive plan for
acquisition of technical and professional skills that will enable my transition to an independent research
position. The successful completion of this project will provide a platform for future experiments aimed to
combine my expertise in stem cell fate decision to gain a deeper understanding of how does these
transcriptional, epigenetic and structural specificities contribute to neurodevelopmental brain disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of BAP1/ASXL3 complex in transcriptional regulation and development-ADMIN SUPPL for Equipment
-
批准号:10799150
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
A Phenotypical Brain Organoids for Neurodevelopmental Disorders
-
批准号:10676198
-
项目类别:
-
资助金额:$10.55万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
Role of BAP1/ASXL3 complex in transcriptional regulation and development
-
批准号:10669750
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2022
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:10600490
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:9977548
-
项目类别:
-
资助金额:$9.94万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:10852142
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Mechanisms of enhancer regulation in aging and age-related diseases
-
批准号:10166757
-
项目类别:
-
资助金额:$9.94万
-
财政年份:2020
-
负责人:Lu Wang
-
依托单位:
Theoretical Modeling of the Vibrational Spectroscopy of Nucleic Acids
-
批准号:10330456
-
项目类别:
-
资助金额:$15.37万
-
财政年份:2019
-
负责人:Lu Wang
-
依托单位:
Plasma Lipid Markers and Cancer Risk
-
批准号:8548295
-
项目类别:
-
资助金额:$8.29万
-
财政年份:2012
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8130777
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8669043
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8534804
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:7989847
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
Vitamin D Status, Vitamin D Receptor Gene Variants, and Hypertension Risk
-
批准号:8503656
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Lu Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: